Menlo Therapeutics Stock Price - MNLO

2.38
-0.01 (-0.42%)
Upgrade to Real-Time
Afterhours (Closed)
2.39
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Menlo Therapeutics Inc MNLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.12 -4.78% 2.39 2.20 2.88 2.60 2.51 00:00:02
Bid Price Ask Price Spread Spread % News
2.24 2.55 0.31 12.16% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
69,802 26,351,275 $ 2.50 $ 65,908,441 4,952,000 1.00 - 7.48
Last Trade Time Type Quantity Stock Price Currency
19:59:07 formt 890 $ 2.38 USD

Menlo Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 325.65M 136.26M 134.98M $ - $ - -3.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 60.00 2.10%

more financials information »

Menlo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNLO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.313.012.062.417,770,1680.083.46%
1 Month1.803.011.402.074,769,6210.5932.78%
3 Months3.114.491.001.913,076,724-0.72-23.15%
6 Months3.847.481.002.121,595,019-1.45-37.76%
1 Year6.547.481.002.21821,089-4.15-63.46%
3 Years20.5039.861.004.48449,788-18.11-88.34%
5 Years20.5039.861.004.48449,788-18.11-88.34%

Menlo Therapeutics Description

Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopitant for the treatment of pruritus associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The pipeline product of the company includes Prurigo Nodularis, Prurigo Dermatitis, Psoriasis and Refractory Chronic Cough.


Your Recent History
NASDAQ
MNLO
Menlo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.